Sort by
Refine Your Search
-
particular suited to a Postdoctoral Researcher who has established expertise and track record in cardiovascular disease, and could benefit from the sustained support of the BHF’s award to develop their career
-
future research into brain-based biomarkers and to (iii) genomic variation, using novel imaging-transcriptomics approaches, e.g., to identify putative treatment targets. To this aim, the successful
-
future research into brain-based biomarkers and to (iii) genomic variation, using novel imaging-transcriptomics approaches, e.g., to identify putative treatment targets. To this aim, the successful
-
postholder will undertake quantitative petrological research to investigate magma storage conditions and timescales of magmatic processes in the lead up to and during selected volcanic eruptions of target
-
molecular therapeutics. Their ability to target challenging biological sites and modulate intracellular functions¿capabilities beyond those of traditional small molecules and biologics¿make them a promising
-
Institute for Molecular and Computational Medicine (IMCM). You will test GSK assets and targets in established models of podocyte and mesangial cell pathology relevant to glomerular diseases. You will
-
particular suited to a Post Doctoral Scientist who has established expertise and track record in cardiovascular disease, and could benefit from the sustained support of the BHF’s award to develop their career
-
to dissect early disease mechanisms and identify potential therapeutic targets for treatment of IPF. Through close links with the Royal Brompton Hospital, there is excellent access to human blood, airway and
-
the research and innovation of next-generation microgrid design and AI-driven optimisation techniques, in order to meet the project’s cost- and carbon-reduction targets. Grade 7 Post Doctoral Research Associate
-
of persisters and infected macrophages during acute infection and antibiotic exposure, using advanced infection model systems; and (2) to identify novel immunomodulatory or persister-targeting strategies